| H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks TM Marti, E Hefner, L Feeney, V Natale, JE Cleaver Proceedings of the National Academy of Sciences 103 (26), 9891-9896, 2006 | 410 | 2006 |
| DNA mismatch repair and mutation avoidance pathways TM Marti, C Kunz, O Fleck Journal of cellular physiology 191 (1), 28-41, 2002 | 361 | 2002 |
| Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin Y Shi, E Felley-Bosco, TM Marti, K Orlowski, M Pruschy, RA Stahel BMC cancer 12, 1-10, 2012 | 135 | 2012 |
| A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids J Ruppen, L Cortes-Dericks, E Marconi, G Karoubi, RA Schmid, R Peng, ... Lab on a Chip 14 (6), 1198-1205, 2014 | 130 | 2014 |
| Translesion DNA synthesis in the context of cancer research PA Knobel, TM Marti Cancer cell international 11, 1-19, 2011 | 99 | 2011 |
| DNA repair nucleases TM Marti, O Fleck Cellular and Molecular Life Sciences CMLS 61, 336-354, 2004 | 99 | 2004 |
| Blocking the epithelial-to-mesenchymal transition pathway abrogates resistance to anti-folate chemotherapy in lung cancer SQ Liang, TM Marti, P Dorn, L Froment, SRR Hall, S Berezowska, ... Cell death & disease 6 (7), e1824-e1824, 2015 | 90 | 2015 |
| Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin LL Belyanskaya, TM Marti, S Hopkins-Donaldson, S Kurtz, E Felley-Bosco, ... Molecular cancer 6, 1-13, 2007 | 82 | 2007 |
| Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells PA Knobel, IN Kotov, E Felley-Bosco, RA Stahel, TM Marti Neoplasia 13 (10), 961-IN28, 2011 | 63 | 2011 |
| HSP90/AXL/eIF4E-regulated unfolded protein response as an acquired vulnerability in drug-resistant KRAS-mutant lung cancer H Yang, SQ Liang, D Xu, Z Yang, TM Marti, Y Gao, GJ Kocher, H Zhao, ... Oncogenesis 8 (9), 45, 2019 | 49 | 2019 |
| mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer SQ Liang, ED Bührer, S Berezowska, TM Marti, D Xu, L Froment, H Yang, ... Oncogene 38 (5), 622-636, 2019 | 45 | 2019 |
| Pol η is required for DNA replication during nucleotide deprivation by hydroxyurea S De Feraudy, CL Limoli, E Giedzinski, D Karentz, TM Marti, L Feeney, ... Oncogene 26 (39), 5713-5721, 2007 | 45 | 2007 |
| Tumor initiation capacity and therapy resistance are differential features of EMT-related subpopulations in the NSCLC cell line A549 CC Tièche, Y Gao, ED Bührer, N Hobi, SA Berezowska, K Wyler, ... Neoplasia 21 (2), 185-196, 2019 | 44 | 2019 |
| Human microvasculature-on-a chip: anti-neovasculogenic effect of nintedanib in vitro S Zeinali, CA Bichsel, N Hobi, M Funke, TM Marti, RA Schmid, OT Guenat, ... Angiogenesis 21, 861-871, 2018 | 44 | 2018 |
| Increased PD-L1 expression and IL-6 secretion characterize human lung tumor-derived perivascular-like cells that promote vascular leakage in a perfusable microvasculature model CA Bichsel, L Wang, L Froment, S Berezowska, S Müller, P Dorn, ... Scientific reports 7 (1), 10636, 2017 | 38 | 2017 |
| Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT CC Tièche, RW Peng, P Dorn, L Froment, RA Schmid, TM Marti BMC cancer 16, 1-15, 2016 | 38 | 2016 |
| The spike gene is a major determinant for the SARS-CoV-2 Omicron-BA. 1 phenotype GT Barut, NJ Halwe, A Taddeo, JN Kelly, J Schön, N Ebert, L Ulrich, ... Nature Communications 13 (1), 5929, 2022 | 37 | 2022 |
| Cisplatin-resistant A549 non-small cell lung cancer cells can be identified by increased mitochondrial mass and are sensitive to pemetrexed treatment Y Gao, P Dorn, S Liu, H Deng, SRR Hall, RW Peng, RA Schmid, TM Marti Cancer cell international 19, 1-14, 2019 | 32 | 2019 |
| Endoplasmic reticulum stress signaling as a therapeutic target in malignant pleural mesothelioma D Xu, H Yang, Z Yang, S Berezowska, Y Gao, SQ Liang, TM Marti, ... Cancers 11 (10), 1502, 2019 | 32 | 2019 |
| CRISPR screening identifies WEE1 as a combination target for standard chemotherapy in malignant pleural mesothelioma D Xu, SQ Liang, H Yang, R Bruggmann, S Berezowska, Z Yang, TM Marti, ... Molecular cancer therapeutics 19 (2), 661-672, 2020 | 31 | 2020 |
